ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $167,000 | -7.2% | 34,073 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $180,000 | +9.8% | 34,115 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $164,000 | +10.8% | 34,115 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $148,000 | +5.0% | 34,215 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $141,000 | +56.7% | 34,215 | -2.8% | 0.00% | 0.0% |
| Q2 2020 | $90,000 | -28.6% | 35,215 | -19.3% | 0.00% | 0.0% |
| Q1 2020 | $126,000 | -16.6% | 43,648 | +9.7% | 0.00% | 0.0% |
| Q4 2019 | $151,000 | -19.7% | 39,791 | +8.4% | 0.00% | -50.0% |
| Q3 2019 | $188,000 | -21.7% | 36,714 | +8.7% | 0.00% | 0.0% |
| Q1 2019 | $240,000 | +14.3% | 33,766 | +37.5% | 0.00% | 0.0% |
| Q4 2018 | $210,000 | +90.9% | 24,553 | +372.0% | 0.00% | +100.0% |
| Q3 2017 | $110,000 | -23.1% | 5,202 | -38.4% | 0.00% | 0.0% |
| Q4 2016 | $143,000 | – | 8,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |